H1 Approvals Seen For Russian, Novavax COVID-19 Vaccines In India

J&J, Pfizer Yet To Begin Local Trials

 
• By Vibha Ravi

Multiple COVID-19 vaccines, including from RDIF and Novavax, could get accelerated approvals in India in the first half of calendar 2021, expanding the range at the country’s disposal. J&J's vaccine is expected to follow although it still hasn’t begun local trials, while Pfizer has temporarily withdrawn an application.

Different types of Covid-19 coronavirus vaccines to protect against disease or pandemic
Two COVID-19 Vaccines Done, Others Set For Indian Regulatory Approval • Source: Shutterstock

More from Vaccines

More from Pink Sheet